Jane V. Aldrich - Lawrence KS, US Kshitij A. Patkar - Lawrence KS, US Jay McLaughlin - Natick MA, US
International Classification:
A61K 38/00 A61K 38/12 C12N 5/00 A61P 25/00
US Classification:
514 9, 514 12, 435375
Abstract:
A dynorphin-A analog can be used for treatment, inhibition, and/or prevention of cocaine seeking behavior, and or the drug seeking behavior for a cocaine derivative or other structurally related substance. The dynorphin-A analog can be a cyclic dynorphin-A analog having sufficient systemic stability that crosses the blood-brain barrier so as to be active in the brain at kappa-opioid receptors (KOR) as an antagonist. Such activity at a KOR as an antagonist can be useful for cocaine management and reducing the desire, such as stress-related desires, for use of cocaine, crack, or the like. The KOR antagonist can be [N-benzylTyr,cyclo(D-Asp,Dap)]Dyn A-(1-11) amide, salt thereof, prodrug thereof, and/or derivative thereof.
FDA - Rockville, MD since Oct 2012
Review Chemist
Torrey Pines Institute for Molecular Studies Sep 2010 - Sep 2012
Senior Scientist, Bioanalytical Chemistry
University of Kansas Mar 2008 - Sep 2010
Research Associate
University of Kansas Feb 2006 - Mar 2008
Post doctoral researcher
The National Institute on Drug Abuse (NIDA) - Baltimore, MD Mar 2003 - Dec 2005
Postdoctoral Reseacher
Education:
University of Maryland Baltimore 1997 - 2002
Doctor of Philosophy (Ph.D.), Pharmaceutical Sciences
University of Mumbai 1991 - 1995
Bachelor of Pharmaceutical Sciences
Skills:
Hplc Lc Ms Mass Spectrometry Chemistry Cell Culture Drug Discovery Peptide Synthesis Cell In Vitro Organic Chemistry Drug Development Maldi Tof Protein Chemistry Western Blotting Sds Page Medicinal Chemistry Organic Synthesis Biochemistry Chromatography Research Peptides Purification Spectroscopy Analytical Chemistry Gel Electrophoresis Uv/Vis Uv Vis Bioanalytical Chemistry Protein Characterization Column Chromatography Drug Design Synthetic Chemistry Electrophoresis Gc Ms Gc/Ms Proteomics Tissue Culture